|
Updated Presentations and Publications Page
|
4
|
Resverlogix Corp.
|
Nov 20, 2015 01:55PM
|
|
Re: New Share Price Contest
|
4
|
Resverlogix Corp.
|
Oct 11, 2019 03:52PM
|
|
Re: From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection
|
4
|
Resverlogix Corp.
|
May 11, 2019 11:26PM
|
|
Re: CKD Reata / Market Cap
|
4
|
Resverlogix Corp.
|
May 04, 2019 08:34PM
|
|
RVX-208 vs. CETP inhibitors
|
4
|
Resverlogix Corp.
|
Aug 18, 2015 04:10PM
|
|
Re: Q4 2017 Events
|
4
|
Resverlogix Corp.
|
Nov 06, 2017 10:49AM
|
|
30th EORTC-NCI-AACR SYMPOSIUM
|
4
|
Zenith Epigenetics
|
Jun 07, 2018 02:45PM
|
|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Mar 25, 2017 11:14AM
|
|
Re: Now the webcast is up
|
4
|
Resverlogix Corp.
|
Mar 11, 2019 01:52PM
|
|
Re: Colchicine
|
4
|
Resverlogix Corp.
|
Feb 05, 2021 06:34AM
|
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 16, 2018 01:57PM
|
|
Re: Sick Patients for Trial Design ... BETonMACE
|
4
|
Resverlogix Corp.
|
Oct 20, 2015 12:06PM
|
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
4
|
Zenith Epigenetics
|
Feb 01, 2018 11:38AM
|
|
Re: AGM - High Level Summary
|
4
|
Zenith Epigenetics
|
Jan 08, 2016 07:18AM
|
|
Zenith Upcoming Events
|
4
|
Zenith Epigenetics
|
Mar 19, 2019 10:18AM
|
|
Re: Why is it taking so long Simple.
|
4
|
Resverlogix Corp.
|
Apr 17, 2019 11:33AM
|
|
Re: Could there be another shoe waiting to drop?
|
4
|
Resverlogix Corp.
|
May 19, 2019 09:55PM
|
|
Re: ESC 2017
|
4
|
Resverlogix Corp.
|
Oct 09, 2017 11:52AM
|
|
Nature Reviews Disease Primer on Atherosclerosis
|
4
|
Resverlogix Corp.
|
Aug 19, 2019 10:42AM
|
|
Novel approaches to targeting BRD4
|
4
|
Zenith Epigenetics
|
Dec 14, 2017 11:24AM
|
